Cargando…

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Microtubule targeting agents (MTAs) are a mainstay in the treatment of a wide range of tumors. However, acquired resistance to chemotherapeutic drugs is a common mechanism of disease progression and a prognostic-determinant feature of malignant tumors. In prostate cancer (PC), resistance to MTAs suc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohr, Lisa, Carceles-Cordon, Marc, Woo, Jungreem, Cordon-Cardo, Carlos, Domingo-Domenech, Josep, Rodriguez-Bravo, Veronica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MyJove Corporation 2017
Materias:	Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607877/ https://www.ncbi.nlm.nih.gov/pubmed/28930981 http://dx.doi.org/10.3791/56327

Ejemplares similares

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
por: Han, Dan, et al.
Publicado: (2019)

Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer
por: Dhital, Brittiny, et al.
Publicado: (2023)

PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer
por: Barber, Alison G, et al.
Publicado: (2015)

A BAC-Based Transgenic Mouse Specifically Expresses an Inducible Cre in the Urothelium
por: Shen, Tian Huai, et al.
Publicado: (2012)

Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cells
por: Lin, Changyi, et al.
Publicado: (2020)

Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
por: Babasaki, Takashi, et al.
Publicado: (2021)

At the Crossroads of Inflammation and Tumorigenesis
por: Cordon-Cardo, Carlos, et al.
Publicado: (1999)

Docetaxel Treatment for Metastatic Hormone-sensitive Prostate Cancer in Daily Practice
por: de Groot, Ietsen, et al.
Publicado: (2021)

Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice
por: Lendorf, Maria Elisabeth, et al.
Publicado: (2021)

Applications of array technology: identification of molecular targets in bladder cancer
por: Sánchez-Carbayo, M, et al.
Publicado: (2003)

Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer
por: Passildas‐Jahanmohan, Judith, et al.
Publicado: (2021)

Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 Is an Independent Prognostic Factor for Aggressive Prostate Cancer
por: Barber, Alison G., et al.
Publicado: (2014)

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
por: Martellucci, Stefano, et al.
Publicado: (2021)

A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer
por: Tsaur, Igor, et al.
Publicado: (2021)

An Aurora kinase inhibitor, AMG900, inhibits glioblastoma cell proliferation by disrupting mitotic progression
por: Ryu, Jaewook, et al.
Publicado: (2018)

Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration‐resistant prostate cancer
por: Pilling, Amanda, et al.
Publicado: (2021)

Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines
por: Donix, Lukas, et al.
Publicado: (2022)

Neutropenia and docetaxel exposure in metastatic castration‐resistant prostate cancer patients: A meta‐analysis and evaluation of a clinical cohort
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2019)

Rational Second-Generation Antiandrogen Use in Prostate Cancer
por: Orme, Jacob J, et al.
Publicado: (2022)

MELK expression correlates with tumor mitotic activity but is not required for cancer growth
por: Giuliano, Christopher J, et al.
Publicado: (2018)

Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation
por: Haimovitz-Friedman, Adriana, et al.
Publicado: (1997)

Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis
por: Alpert, Evgenia, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
por: Sheehan, Beshara, et al.
Publicado: (2022)

BAD sensitizes breast cancer cells to docetaxel with increased mitotic arrest and necroptosis
por: Mann, Jasdeep, et al.
Publicado: (2020)

Interaction of Docetaxel with Phosphatidylcholine Membranes: A Combined Experimental and Computational Study
por: Aranda, Elisa, et al.
Publicado: (2022)

BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer
por: Weaver, Robbyn L, et al.
Publicado: (2016)

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
por: Yekedüz, Emre, et al.
Publicado: (2023)

Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study)
por: Woo, Henry H., et al.
Publicado: (2022)

DAG Expression: High-Throughput Gene Expression Analysis of Real-Time PCR Data Using Standard Curves for Relative Quantification
por: Ballester, María, et al.
Publicado: (2013)

Pten Dose Dictates Cancer Progression in the Prostate
por: Trotman, Lloyd C, et al.
Publicado: (2003)

Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations
por: Häggström, Christel, et al.
Publicado: (2014)

Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck
por: Schell, Amy, et al.
Publicado: (2015)

ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patients
por: Patil, Anand, et al.
Publicado: (2021)

Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells
por: Martino, Julieta, et al.
Publicado: (2023)

The Role of Isolation Methods on a Nanoscale Surface Structure and its Effect on the Size of Exosomes
por: Woo, JungReem, et al.
Publicado: (2016)

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
por: Aleman, A, et al.
Publicado: (2008)

Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression
por: Rego, Eduardo M., et al.
Publicado: (2001)

Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia
por: Hamdan, Diaddin, et al.
Publicado: (2019)

Undifferentiated prostate cancer treated with docetaxel
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Depletion of Survivin suppresses docetaxel-induced apoptosis in HeLa cells by facilitating mitotic slippage
por: Han, Teng-Long, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3b0k3amp1gj1psq316qinaj498